Updated List of Pigmentary genes
by: Laura L. Baxter, Lluís Montoliu, William J. Pavan and Stacie K. Loftus
Based on: Baxter, L. L., Watkins-Chow, D. E., Pavan, W. J., & Loftus, S. K. (2019). A curated gene list for expanding the horizons of pigmentation biology. Pigment cell & melanoma research, 32(3), 348–358. https://doi.org/10.1111/pcmr.12743
Current number of genes listed: 662
Last update: 2 March 2021
(*) Genomic duplications often result in paralogous genes; if paralogs were present that both show orthology to one of the other species listed here, then both are indicated. The alliancegenome.org links for each gene provide a detailed table describing the criteria used to determine orthologs across species.
The alliancegenome.org links associated with each gene provide a comprehensive resource of information, including: orthology, function - GO annotations, phenotypes, disease associations, alleles and variants, transgenic alleles, models, sequence feature viewer, expression and molecular interactions.
Human gene
|
Human paralog*
|
Mouse gene
|
Mouse paralog*
|
Zebrafish gene
|
Zebrafish paralog*
|
Human disease with hair and/or skin pigmentary phenotype (#OMIM)
|
Human pigmentation phenotype
|
Mouse pigmentation phenotype
|
Zebrafish pigmentation phenotype
|
Cell-based phenotype / other organism phenotype
|
|
|
|
Pigmentation disrupted | |||||||
|
|
|
Dyschromatosis universalis hereditaria 3
(#61402) |
Hyperpigmentation and hypopigmentation; symmetrical hyper- and hypopigmented macules that appear in infancy or early childhood on trunk, limbs, and face | Head melanocyte decreased amount | |||||
|
|
|
Pigment cell quality, abnormal; pigmentation arrested; reduced pigmentation in eye | |||||||
|
|
|
|
Hyperpigmentation, increased ear and skin and tail pigmentation, adrenocortical dysplasia (acd) | ||||||
|
|
Gray coat color; congenital graying in compound mutant of Bmpr2 (melanocyte-specific ko of Bmpr2) along with germline mutant of Acvr2a, Acvr2a+/-; Bmpr2flox/flox; K14-Cre (conditional), disorganized and clumping pigment present in hair medulla--smaller melanosomes that are still transferred to hair shaft, PMID: 22611050 | ||||||||
|
|
Reticulate acropigmentation of Kitamura
(#615537) |
Hyperpigmentation; reticulate macules on dorsa of hands and feet | Freckle-like macules occur in hairless mice that are heterozygous for the Pied mutation, which is a deletion in Adam10, PMID: 22834956 | ||||||
|
|
Irregular and dense pigmentation patterns within pelage hairs, altered hair follicle morphology | ||||||||
|
|
|
|
White spotting, belly spot, belted (bt) | ||||||
|
|
|
More reduced melanoblast number seen in Adamts20+/- mice or Adamts20-/- mice that were also haploinsufficient for Adamts9, as compared to Adamts20 mutation alone, PMID: 18454205 | |||||||
|
|
|
Dyschromatosis symmetrica hereditaria
(#127400) |
Hyperpigmented/hypopigmented macules (dorsum of hands and feet, face) | ||||||
|
|
|
Establishment of melanosome localization increased occurrence, abnormal | |||||||
|
|
|
Pigmentation process quality, abnormal; melanophore stripe broken | |||||||
|
|
|
Integument melanosome decreased amount; integument melanosome decreased pigmentation | |||||||
|
|
|
Hypopigmentation, hypopigmented feet and tail | |||||||
|
|
|
|
|
Hair graying in double KO with Afg3l2; Afg3l1 was whole animal null, while Afg3l2 was Tamoxifen-induced Cre-mediated targeting to oligodendrocyte lineage in adult mice (conditional); graying started ventrally, then spread dorsally | |||||
|
|
|
Hair graying in double KO with Afg3l1; Afg3l1 was whole animal null, while Afg3l2 was Tamoxifen-induced Cre-mediated targeting to oligodendrocyte lineage in adult mice (conditional); graying started ventrally, then spread dorsally | |||||||
|
|
|
Melanocyte quality, abnormal | |||||||
|
|
|
Integument melanocyte decreased contractility, abnormal, integument melanocyte spatial pattern, abnormal | |||||||
|
|
Hyperpigmentation on footpads | ||||||||
|
|
|
Pigment cell decreased amount; whole organism pigmented, abnormal | |||||||
|
|
|
Pigmentation decreased occurrence, abnormal | |||||||
|
|
|
Rodent phenotype (Rhabdomys pumilio); developmentally regulates striping pattern | |||||||
|
|
ambra1a = pigmentation delayed / ambra1b = pigmentation delayed | ||||||||
|
|
|
Cell-based phenotype; Anxa2 KD reduces melanin content; BLOC-1-KIF13A-Annexin A2 molecular network regulates recycling endosome tubules, PMID: 26725201 | |||||||
|
|
|
Pigmentation decreased occurrence, abnormal | |||||||
|
|
HPS2, Hermansky-Pudlak syndrome 2
(#608233) |
Oculocutaneous albinism and fair hair | Diluted coat color, white spotting, hypopigmentation, abnormal skin pigmentation; decreased eye pigmentation, pearl (pe) | ||||||
|
|
|
HPS10, Hermansky-Pudlak syndrome 10
(#617050) |
Oculocutaneous albinism, hypopigmented hair | Diluted coat color, abnormal retinal pigment epithelium, decreased eye pigmentation, mocha | |||||
|
|
|
Melanocyte decreased pigmentation | |||||||
|
|
|
Skin morphology alterations; Abnormal skin pigmentation, increased ear and forehead pigmentation, dark median line, delayed hair growth, abnormal keratinocyte differentiation, Apctm2Rak/Apctm2Rak; Tg(KRT14-cre)8Brn/0 (conditional) | |||||||
|
|
Diluted coat color, pale coat neuro | ||||||||
|
|
|
Melanosome transport decreased rate, abnormal | |||||||
|
|
|
Iridophore decreased amount; melanocyte decreased amount | |||||||
|
|
|
Diluted coat color, yellow coat color, decreased ear and tail pigmentation, agouti (a) | Melanocyte increased amount; melanophore stripe dorsalized, abnormal | ||||||
|
|
|
|
|
Trunk melanosome increased area, abnormal | |||||
|
|
|
Patches of red hair among black hair, 10% of surviving mice, Ate1tm1Avar/Ate1tm2.1Avar; Tg(CAG-cre/Esr1*)5Amc/0 (conditional) | |||||||
|
|
|
Hypopigmentation of the epidermis; Atg7 f/f; Tyr::Cre (conditional); Atg7 KO in melanocytes suppresses autophagy, melanin content of hair decreased by 10–15%, PMID: 25290687 | |||||||
|
|
|
Ataxia-telangiectasia
(#208900) |
Hyperpigmentation, cafe au lait spots | ||||||
|
|
|
Pigment cell quality, abnormal | |||||||
|
|
|
Hypopigmentation, copper metallochaperone | |||||||
|
|
|
Melanocyte morphology, abnormal | |||||||
|
|
|
Melanocyte decreased pigmentation; melanocyte increased size, abnormal: melanosome organization process quality, abnormal: retinal pigmented epithelium melanosome decreased size, abnormal; retinal pigmented epithelium melanosome broken | |||||||
|
|
|
Whole organism unpigmented; pigment cell quality, abnormal; retinal pigmented epithelium disorganized | |||||||
|
|
|
Integument colorless; whole organism colorless; eye discolored | |||||||
|
|
|
Melanocyte decreased pigmentation; eye pigmentation disrupted | |||||||
|
|
|
Eye pigment granule organization process quality, abnormal; trunk decreased pigmentation | |||||||
|
Melanocyte decreased pigmentation; retinal pigmented epithelium quality, abnormal; trunk decreased pigmentation | |||||||||
|
|
|
Eye decreased pigmentation; trunk unpigmented | |||||||
|
|
|
Eye color, abnormal; melanocyte malformed; pigmentation decreased occurrence, abnormal | |||||||
|
|
|
Menkes disease
(#309400) |
Skin hypopigmentation and silvery hair, hair "steely" and "white" | Irregular coat pigmentation, absent coat pigmentation, copper transporter, mottled (Mo) | Pigmentation disrupted | ||||
|
|
|
|
Diluted coat color, hypopigmentation, toxic milk (tx) | ||||||
|
|
|
Hair graying, Atrtm1Bal/Atrtm2Bal; Ndor1Tg(UBC-cre/ERT2)1Ejb/0 (conditional) | |||||||
|
|
|
Darkened coat color, suppresses Agouti pigment type switching, mahogany (mg) | |||||||
|
|
|
Diluted, silver gray coat color, altered melanosome morphology in dermal melanocytes and RPE, functions to process PMEL, PMID:26912421, reduced melanin in hair shaft and uvea of eye, diluted (gray) coat color when treated with BACE inihibitor (inhibits BACE1 and BACE2), PMID: 23754390 | Melanocyte migration disrupted; melanocyte dilated, abnormal | ||||||
|
|
|
Hair follicle alterations; Abnormal coat/hair pigmentation, skin pigmentation, delay in the anterior to posterior clearing of pigments that occurs during the hair cycle | |||||||
|
|
|
Melanosome transport delayed, abnormal | |||||||
|
|
|
Melanosome transport delayed, abnormal; retina layer formation process quality, abnormal | |||||||
|
|
|
Melanosome transport delayed, abnormal; retinal pigmented epithelium ventral region absent | |||||||
|
|
|
Melanosome transport delayed, abnormal | |||||||
|
|
|
Melanosome transport delayed, abnormal | |||||||
|
|
|
Diluted coat color, gray coat color, hypopigmentation, irregular coat pigmentation | |||||||
|
|
|
Abnormal coat/hair pigmentation, graying hair, in combination with BCL2; PMID: 11709185 | |||||||
|
|
|
Heterozygous Becn1 mouse mutant shows hypopigmentation of coat; PMID: 19057677 | |||||||
|
|
|
Bloom syndrome
(#210900) |
Hypopigmented and hyperpigmented skin, sun-sensitivity, café au lait macules | ||||||
|
|
|
HPS8, Hermansky-Pudlak syndrome 8
(#614077) |
Hypopigmentation of skin and hair; retinal hypopigmentation | Diluted coat color, decreased ear and tail pigmentation, abnormal melanosome morphology, abnormal eye pigmentation, reduced pigmentation (rp) | |||||
|
|
|
Diluted coat color, abnormal melanosome morphology, decreased eye pigmentation, abnormal retinal pigmentation, cappuccino (cno) | |||||||
|
|
|
HPS11, Hermansky-Pudlak syndrome 11
(#619172) (2 patients) |
Oculocutaneous albinism, hypopigmented hair | Diluted coat color, abnormal melanosome morphology, decreased eye pigmentation, abnormal retinal pigmentation, hypopigmentation, muted (mu) | |||||
|
|
|
HPS9, Hermansky-Pudlak syndrome 9
(#614171) |
Oculocutaneous albinism, hypopigmented hair | Diluted coat color, abnormal melanosome morphology, decreased eye pigmentation, ocular albinism | |||||
|
|
|
Melanocyte decreased amount | |||||||
|
|
PMID:22611050, Gray coat color; congenital graying in compound mutant of Bmpr2 (melanocyte-specific KO) with germline mutant with Acvr2a, Acvr2a+/-; Bmpr2flox/flox; K14-Cre (conditional); disorganized and clumping pigment present in hair medulla--smaller melanosomes that are still transferred to hair shaft | ||||||||
|
|
|
Melanocyte decreased amount; melanophore stripe malformed: trunk iridophore decreased amount; xanthophore decreased amount | |||||||
|
|
|
Melanocyte-specific KO shows premature graying after first hair cycle; PMID: 26440048 | |||||||
|
|
|
LEOPARD syndrome 3
(#613707) Cardiofaciocutaneous syndrome type 1 (#115150) |
LEOPARD syndrome = Pigmented lesions, lentigines, café au lait spots; Cardiofaciocutaneous syndrome = multiple lentigines | Melanocytic nevus-like hyperplasia and melanoma in transgenic BRAFV600E mice, Braftm1Cpri/Braftm1Cpri; Tg(Tyr-cre/ERT2)1Lru/0 (conditional); also hair graying in mice with double knockout for Braf and Raf1 (c-raf), B-raff/f; C-raff/f; Tyr::Cre/°; Dct::LacZ/° or B-raff/f; C-raff/f; Tyr::Cre/°; Z/EG/° (conditional), PMID: 23022482 | |||||
|
|
|
|
Hair graying after gamma-irradiation, skin pigmentation defects | ||||||
|
|
|
Fanconia anemia FANCD1
(#605724) |
Hyperpigmentation, cafe au lait spots | ||||||
|
|
|
Fanconia anemia FNACJ
(#609054) |
Hyperpigmentation, cafe au lait spots | ||||||
|
|
|
Abnormal coat/hair pigmentation, by day 14, Btd null mice fed a biotin-depleted diet exhibit whitening of the fur around the eyes and subsequent graying of the fur over the entire body | |||||||
|
|
|
Abnormal coat/hair pigmentation, irregular coat pigmentation, ventral coat is lighter resembling at or Aw; white feet and tail tip observed; yellow hair absent from ears, dense incisors (din) | |||||||
|
|
|
Melanosome transport delayed, abnormal | |||||||
|
|
|
Whole organism decreased pigmentation | |||||||
|
|
|
Melanocyte pigment granule movement quality, abnormal; retinal pigmented epithelium pigment granule movement quality, abnormal | |||||||
|
|
|
|
|
Pigmentation decreased occurrence, abnormal | |||||
|
|
|
Darkened coat color, abnormal foot pigmentation, increased ear pigmentation, increased tail pigmentation | |||||||
|
|
Homocystinuria
(#236200) |
Hypopigmentation of skin and hair | |||||||
|
|
|
Pigmentation process quality, abnormal | |||||||
|
|
|
Melanosome transport disrupted, abnormal | |||||||
|
Melanosome transport disrupted, abnormal | |||||||||
|
|
|
PMID: 28238662,white spotting, extensive ventral white spotting, small patches of dorsal white spotting, hypopigmented paws and tail; Cdc42 f/f; Tyr::CreB+ (conditional) | Melanosome transport disrupted; melanocyte decreased amount, abnormal | ||||||
|
|
|
Melanocyte decreased amount, abnormal | |||||||
|
|
|
Pigment cell development disrupted | |||||||
|
|
|
Melanocyte differentiation delayed; eye pigmentation disrupted; axis melanoblast mislocalised medially | |||||||
|
|
|
|
Hypotrichosis with juvenile macular dystrophy (HJMD)
(#601553) ectodermal dysplasia, ectrodactyly, and macular dystrophy (EEMS) (#225280) |
Retinal changes with prominent pigmentation in macular dystrophy, patients show unusually fair hair when compared to sibs | |||||
|
|
|
PMID: 29062096, diluted coat color, lighter brown coat color visible by 4 weeks (on C57Bl6 background), KD was from transgenic shRNA targeting Cdk5, polarized melanin distribution, at 8 weeks, sparse hair and skin plaques, thickened epidermis | |||||||
|
|
|
Abnormal coat/hair pigmentation, hair graying at 8 months of age in mice exposed to a tamoxifen diet from weaning, Cdk7Gt(D032B11)1.1Wrst/ Cdk7Gt(D032B11)1.1Wrst; Ndor1Tg(UBC-cre/ERT2)1Ejb/0 (conditional) | |||||||
|
|
|
Melanoma and neural system tumor syndrome
(#155755) |
Atypical and dysplastic nevi, susceptibility to cutaneous malignant melanoma | ||||||
|
|
White spotting, belly spot; PMID: 26952979, knockdown of function of all CDX family proteins by engrailed repressor spliced to CDX1; mice carrying additional KO of Cdx1 increases white spotting | ||||||||
|
|
|
Melanosome transport delay; PMID: 24550735 | |||||||
|
|
|
Melanosome transport decreased rate; whole organism decreased pigmentation | |||||||
|
|
|
Whole organism decreased pigmentation | |||||||
|
|
|
Eye iridophore absent; whole organism melanocyte shape, abnormal; whole organism decreased pigmentation | Cell-based phenotype; regulates neural crest development/differentiation | ||||||
|
|
|
PMID: 23557358, deletion of Chek1 in melanocytes (Tyr::Cre transgene, conditional) showed complete absence of hair/skin pigmentation; melanoblasts specified at normal numbers, but lost to apoptosis starting at E12.5 | |||||||
|
|
|
Whole organism decreased pigmentation | |||||||
|
|
|
Abnormal coat/hair pigmentation, early depigmentation and gray hair are present on top of the head and on the shoulders, at 48 weeks, mice exhibit premature fur depigmentation | |||||||
|
|
|
Cell-based phenotype; expression in B16 melanocytes increases pigment, PMID: 11434569 | |||||||
|
|
|
Hypopigmentation, organomegaly, and delayed myelination and development
(#618541)(2 patients) |
Cutaneous hypopigmentation, hypopigmented hair --note no osteopetrosis; PMID:31155284 | PMID: 24820037, gray fur in knockout on agouti background, also retinal degeneration; PMID: 31155284, gain-of-function mutation, hypopigmented fur, abnormal lysosomal storage, abnormal brain myelination, no osteopetrosis | |||||
|
|
Hair graying | ||||||||
|
|
|
Whole organism decreased pigmentation | |||||||
|
|
|
|
Whole organism decreased pigmentation | ||||||
|
|
|
Pigment cell spatial pattern, abnormal | |||||||
|
|
|
Belly spot | |||||||
|
|
|
Melanocyte melanosome absent | |||||||
|
|
|
Trunk melanosome absent | |||||||
|
|
|
Melanocyte melanosome absent | |||||||
|
|
|
Diluted coat color, mice exhibit a lighter coat color that is most pronounced in juveniles and persists through adulthood, many awl hairs are yellow instead of black | |||||||
|
|
|
Pigment cell decreased amount | |||||||
|
|
|
Melanocyte cellular pigment accumulation occurrence, abnormal; melanocyte cellular response to light intensity decreased occurrence, abnormal; melanocyte melanosome aggregated, abnormal | |||||||
|
|
|
Trunk iridophore decreased amount | |||||||
|
|
|
Melanocyte differentiation delayed; retinal pigmented epithelium poorly differentiated | |||||||
|
|
|
Melanocyte melanosome immature; melanocyte melanosome circular, abnormal | |||||||
|
|
|
Melanocyte melanosome aggregated, abnormal; melanosome localization disrupted | |||||||
|
|
|
Head xanthophore irregular spatial pattern: iridophore pigmentation process quality, abnormal: melanocyte decreased amount; melanophore stripe melanocyte decreased amount | |||||||
|
|
|
Hyperpigmentation of skin; keratinocyte-specific KO in Csnk1a1fl/fl; K14-Cre-ERT2 mice (conditional): p53-dependent, PMID: 28878021 | |||||||
|
|
|
Melanocyte increased amount, abnormal | |||||||
|
|
|
Cerebroretinal microangiopathy with calcifications and cysts-1 (CRMCC1)
(#612199) |
Graying hair; reticulated skin hyperpigmentation | ||||||
|
|
|
|
Immune-system related, variable depigmentation, 1 in 6 mice develop autoimmune vitiligo | ||||||
|
|
|
Abnormal melanoblast proliferation, white coat for loss-of-function in melanocytes, b-cateninfloxed/floxed; Tyr::Cre (conditional), gray coat for gain-of-function in melanocytes, activated b-catenin transgenic, PMID: 21862558, also, abnormal melanogenesis, Ctnnb1tm1Yy/Ctnnb1tm1Yy; Tg(Prrx1-cre)1Cjt/0 (conditional) | |||||||
|
|
|
Cystinosis
(#219800) |
Hypopigmentation of skin and hair; abnormal retinal pigmentation | ||||||
|
|
|
Melanocyte absent; pigmentation arrested | |||||||
|
|
|
Integument increased pigmentation; retina lacks all parts of type retinal pigmented epithelium microvillus | |||||||
|
|
|
Melanophore stripe melanocyte decreased amount, abnormal | |||||||
|
|
Adrenal insufficiency, congenital, with 46XY sex reversal, partial or complete
(#613743) |
Hyperpigmentation | |||||||
|
|
|
OCA8, Oculocutaneous albinism type 8
(#619165) (2 patients) |
Mild oculocutaneous albinism, hair hypopigmentation | Diluted coat color, abnormal iris color, slaty (slt) | |||||
|
|
|
Cell-based phenotype; regulates melanosome transport; KD causes melanosome dispersal to cell periphery, is a phenocopy of melanoregulin kd in ashen cells; phenocopy seen for KD of RILP, DCTN1 (aka p150Glued), and overexpression of DCTN2; PMID: 22275436 | |||||||
|
|
|
Cell-based phenotype; regulates melanosome transport; overexpression causes melanosome dispersal to cell periphery, is a phenocopy of melanoregulin kd in ashen cells; phenocopy seen for KD of RILP, DCTN1 (aka p150Glued), and overexpression of DCTN2; PMID: 22275436 | |||||||
|
|
|
Xeroderma pigmentosum XPE
(#278740) |
Pigmented or depigmented macules and patches | ||||||
|
|
Syndromic X-linked mental retardation of the Snijders Blok type (MRXSSB)
(#300958) |
Pigmentary skin anomalies | |||||||
|
|
|
|
|
Melanocyte displaced to neural tube ventral surface, abnormal | |||||
|
|
|
Melanocyte irregular spatial pattern; xanthophore quality, abnormal | |||||||
|
|
|
Reduced pigmentation, reduced melanocyte number in body; PMID: 30840854 | |||||||
|
|
|
Developmental pigmentation delayed | |||||||
|
|
|
Pigmentation occurrence, abnormal | |||||||
|
|
|
X-linked dyskeratosis congenita (DKCX)
(#305000) |
Reticulated skin hyperpigmentation | ||||||
|
|
|
Pigmentation increased amount | |||||||
|
|
|
Melanocyte decreased amount; xanthoblast neural crest cell aggregated, abnormal | |||||||
|
|
|
Pigmentation disrupted | |||||||
|
|
|
Diluted coat color; belly spot; abnormal skin pigmentation; abnormal digit pigmentation; non-pigmented tail tip, misty (m), moonlight (mnlt) | |||||||
|
|
|
Darkened coat, hyperpigmentation, increased alpha-MSH levels | |||||||
|
|
|
|
Skin morphology alterations; Abnormal skin pigmentation, at 4-8 weeks of age, the skin is slightly darker in color, thick dermal layer, alopecia, lanceolate hair | ||||||
|
|
|
Spastic paraplegia 23
(#270750) |
Premature hair graying, café au lait spots, hypopigmentation of skin regions | ||||||
|
|
HPS7, Hermansky-Pudlak syndrome 7
(#614076) |
Oculocutaneous albinism and fair hair | Diluted coat color, decreased eye pigmentation, fewer melanosomes in RPE, sandy (sdy) | dtnbp1a = Melanin decreased amount, abnormal | |||||
|
|
|
Melanosome localization process quality, abnormal; melanocyte distended, abnormal; pigmentation process quality, abnormal | |||||||
|
|
|
Melanosome transport delayed | |||||||
|
|
|
Pigment cell quality, abnormal; pigmentation delayed; whole organism decreased pigmentation | |||||||
|
|
|
Abnormal epidermal melanocyte morphology (dorsal skin melanocytes missing), abnormal choroid melanocyte morphology (melanocytes missing), abnormal harderian gland pigmentation (missing melanocytes) | |||||||
|
|
|
Iridophore decreased amount; melanocyte decreased pigmentation | |||||||
|
|
|
Abnormal hair follicle melanocyte morphology, irregular coat/hair pigmentation, abnormal skin pigmentation, transverse fur striping (missing agouti band leads to darker hair), tabby (Ta) | |||||||
|
|
|
Hair follicle alterations; Darkened coat color, reduced hairs with yellow banding in agouti mice, absence of the guard and zig-zag hairs, and presence abnormalities in intermediate hair types (awl and auchene), PMID: 17148670, downless (dl) | |||||||
|
|
|
Abnormal coat / hair pigmentation, abnormal skin pigmentation, copper-related, Agouti is modified-- the back is blacker, the flanks are yellower than normal, crinkled (cr) | |||||||
|
|
|
PMID: 27134165, transgenic mice with Edn1 expressed in keratinocytes, K14-rtTA; TetO-Edn1- lacZ, increased melanocyte stem cell proliferation and differentiation, also, when combined with Mc1R targeted KO in melanocytes (Tyr-CreER;Mc1Rfl/fl; K14-rtTA; tetO-Edn1-LacZ), showed rescue of wound healing melanocyte phenotype | |||||||
|
|
Waardenburg syndrome 4B
(#613265) |
Hypopigmented skin regions on face trunk and limbs; hypopigmented forelock, eyebrows, and eyelashes; premature graying; hypopigmented irides | Darkened coat color, abnormal ear pigmentation, abnormal skin pigmentation, abnormal melanosome morphology, lethal spotting (ls) | edn3b = melanocyte shape, abnormal; melanocyte decreased pigmentation | |||||
|
|
|
Waardenburg syndrome 4A
(#277580) ABCD syndrome (#600501) |
WS4A, hypopigmentation, hypopigmented skin patches, forelock, eyebrows, and eyelashes; Heterochromia irides; premature graying; ABCD syndrome; black lock, retinal depigmentation | Belly spot, head spot, white spotting, variable body spotting, abnormal choroid pigmentation, piebald | Iridophore absent; melanocyte absent; xanthophore spatial pattern, abnormal; trunk melanophore stripe malformed; trunk melanocyte decreased amount | ||||
|
|
|
Hair follicle alterations; Diluted coat color, hair follicle alterations, PMID: 26994968 | |||||||
|
|
|
Skin morphology alterations; Increased foot pad pigmentation, thick epidermis | |||||||
|
|
|
Cellular pigmentation decreased occurrence | |||||||
|
|
|
White spotting, belly spot, extra-toes spotting | |||||||
|
|
|
Melanocyte mislocalised; melanocyte decreased pigmentation | |||||||
|
|
|
Pigment cell quality, abnormal; pigmentation delayed; whole organism decreased pigmentation | |||||||
|
|
|
Pigmentation decreased occurrence | |||||||
|
|
|
Whole organism decreased pigmentation | |||||||
|
|
Abnormal digit hyperpigmentation, hyperpigmented nail structures, abnormal hair follicle development | ||||||||
|
|
|
Cole disease
(#615522) |
Hypopigmentation, primarily on extremites; reduction in melanin content in keratinocytes | ||||||
|
|
|
Vici syndrome
(#242840) |
Hypopigmentation of skin and hair; cutaneous albinism, ocular albinism, retinal hypopigmentation | ||||||
|
|
|
Melanophore stripe irregular spatial pattern; melanocyte spatial pattern, abnormal; xanthophore decreased amount | |||||||
|
|
|
Xeroderma pigmentosum XPD
(#278730) |
Pigmented or depigmented macules and patches | White spotting, hair graying with age | |||||
|
|
|
Xeroderma pigmentosum XPB
(#610651) |
Pigmented or depigmented macules and patches, freckling | ||||||
|
|
|
Xeroderma pigmentosum XPF
(#278760) |
Pigmented or depigmented macules and patches | ||||||
|
|
|
Xeroderma pigmentosum XPG
(#278780) |
Pigmented or depigmented macules and patches | ||||||
|
|
|
UV-sensitive syndrome-1 (UVSS1)
(#600630) |
Pigmented or depigmented macules and patches | ||||||
|
|
|
Roberts syndrome, SC phocomelia syndrome
(#268300) |
Roberts syndrome, hyperpigmentation and hypopigmentation, café au lait spots, silvery blond hair; SC phocomelia syndrome, silvery blond hair | Integument decreased pigmentation | |||||
|
|
|
Head blaze, white spotting, belly spot, variable spotting | |||||||
|
|
|
Melanosome transport delayed | |||||||
|
|
tlcd3ba = pigment cell decreased amount | ||||||||
|
|
|
Fanconia anemia FANCA
(#227650) |
Hyperpigmentation; cafe au lait spots | ||||||
|
|
|
Fanconia anemia FANCC
(#227645) |
Hyperpigmentation; cafe au lait spots | ||||||
|
|
|
Fanconia anemia FANCD2
(#227646) |
Hyperpigmentation; cafe au lait spots | ||||||
|
|
|
Fanconia anemia FANCE
(#600901) |
Hyperpigmentation; cafe au lait spots | ||||||
|
|
|
Fanconia anemia FANCI
(#609053) |
Hyperpigmentation; cafe au lait spots | ||||||
|
|
|
|
|
Melanocyte absent | |||||
|
|
|
Pigment cell quality, abnormal | |||||||
|
|
|
Pigment cell irregular spatial pattern | |||||||
|
|
|
Crouzon syndrome with acanthosis nigricans
(#612247) |
Acanthosis nigricans, hyperpigmentation, hypopigmentation of surgical scars, melanocytic nevi | ||||||
|
|
Pigmentation decreased process quality, abnormal | ||||||||
|
|
|
Hypopigmentation, diluted coat color, pale tremor (plt) | |||||||
|
|
|
Terminal osseous dysplasia
(#300244) |
Pigmentary skin anomalies on face and scalp | ||||||
|
|
|
Prader-Wili-like form of Fragile X (FXS)
(#300624) |
Hyperpigmentation, periorbital, axillary, or genital | ||||||
|
|
|
Melanocyte decreased amount; iridophore decreased amount; melanophore irregular spatial pattern; xanthophore decreased amount | |||||||
|
|
|
Pigmentation delayed | |||||||
|
|
|
Skin morphology alterations; Reduced hair shaft melanin granule number; hairless and abnormal skin pigmentation; color oscillation across different regions becomes out of phase, ultimately resulting in evenly spaced bands of pigment that appear to travel across the body, nude (nu) | |||||||
|
|
Reduced pigmentation in vivo in response to forskolin; PMID: 29463842 | Cell-based phenotype; KD reduces pigmentation in cell cuture | |||||||
|
|
Variable body spotting | frem2a = melanocyte quality, abnormal | |||||||
|
|
PMID: 23633513, White belly spotting in KO mice | ||||||||
|
|
|
Melanocyte mislocalised | |||||||
|
|
|
Diluted coat color, light black (C57Bl6J background) or silver (agouti background) | |||||||
|
|
|
Pigmentation disrupted; melanocyte pigment granule decreased amount; xanthophore pigment granule decreased amount; retinal pigmented epithelium decreased pigmentation; iridophore pigment granule decreased amount | |||||||
|
|
|
Pigmentation process quality, abnormal | |||||||
|
|
|
Skin morphology alterations; Abnormal hair follicle melanin granule morphology, abnormal epidermal layer morphology, Gata3tm3Gsv/ Gata3tm3Gsv; Tg(KRT14-cre)8Brn/0 (conditional), also Gata3jal/Gata3jal mice show abnormal epidermal layer morphology, abnormal hair shaft melanin granule distribution | |||||||
|
|
|
Head has fewer parts of type melanocyte | |||||||
|
|
|
Pigmentation process quality, abnormal; whole organism colorless | |||||||
|
|
|
|
Cell-based phenotype; GDF15 overexpression by fibroblasts induces melanin formation in human primary melanocytes, and KD reduces melanogenesis; PMID: 32416083 | ||||||
|
|
|
Pigment cell decreased amount | |||||||
|
|
|
Melanocyte decreased amount; melanocyte differentiation disrupted | |||||||
|
|
Diluted coat color, appear gray, dwarf grey | ||||||||
|
|
|
Iridophore pigmentation process quality, abnormal; melanophore stripe absent; whole organism dappled | |||||||
|
|
|
Iridophore pigmentation process quality, abnormal; melanocyte absent; melanophore stripe broken; pigmentation disrupted; xanthophore absent | |||||||
|
|
|
Belly spot, hypopigmentation, extra toes | |||||||
|
|
|
Whole organism decreased pigmentation | |||||||
|
|
|
Iridophore pigment granule decreased amount: melanocyte pigment granule decreased amount; xanthophore pigment granule decreased amount | |||||||
|
|
Darkened coat color, increased ear pigmentation, increased foot pad and tail pigmentation, hyperpigmentation | ||||||||
|
|
|
Ocular albinism
(#139370) |
PMID:27607449, Ocular albinism; pigmentation abnormalities; hypopigmentation: affected males have subtly lighter hair and skin than their unaffected siblings | ||||||
|
|
|
Hyperpigmentation, darkened coat color, increased ear pigmentation, abnormal dermal pigmentation, Increased foot pad and tail pigmentation | |||||||
|
|
|
McCune-Albright syndrome
(#174800) |
Large cafe au lait spots | ||||||
|
|
|
Melanocyte morphology, abnormal | |||||||
|
|
|
Iridophore decreased amount; xanthophore decreased amount | |||||||
|
|
|
White spotting, belly spot | |||||||
|
|
|
Cell-based phenotype; hyperpigmentation, mediates estrogen steroid effects on human pigment synthesis; shown in vitro and in organotypic skin tissue; also agonists shown to have an effect in mouse ear, PMID: 2711534 | |||||||
|
|
|
Amyloidosis, primary localized cutaneous, 3 (PLCA3)
(#617920) |
Hyperpigmented and hypopigmented macules | Cell-based melanocyte phenotype; si-mediated KD causes reduced melanosomes | |||||
|
|
|
Ocular albinism, type I (OA1), Nettleship-Falls type
(#300500) |
Mild skin hypopigmentation; ocular albinism | Abnormal melanosome morphology, abnormal iris pigment epithelium, abnormal retinal pigment epithelium | Retinal pigmented epithelium melanosome decreased amount, retinal pigmented epithelium decreased pigmentation | ||||
|
|
Belly spot, PMID: 28135291; MOLF background increases belly spot incidence, vacuolated lens (vl) | ||||||||
|
|
|
Skin morphology alterations; Hypopigmentation, visible at 4 days, altered epidermal differentiation, Gpr89tm1.1Ymae/Gpr89tm1.1Ymae; Tg(KRT5-cre)1Tak/0 (conditional) | |||||||
|
|
|
Pigmentation disrupted | |||||||
|
|
Hyperpigmentation, Tg(Dct-Grm1)ESzc/0 (transgenic) | ||||||||
|
|
|
Belly spot | |||||||
|
|
|
Whole organism decreased pigmentation | |||||||
|
|
KD caused reduced melanocyte precursors, adult melanocyte number, and impaired adult melanocyte regeneration; PMID: 32098766 | Cell-based phenotype; KD reduced melanocyte precursors from mouse embryonic stem cells | |||||||
|
|
|
Melanocyte decreased amount; xanthoblast decreased amount | |||||||
|
|
|
Skin morphology alterations; Increased foot pad and tail pigmentation, epidermal hyperplasia Hdac1tm1.1Eno/Hdac1tm1.1Eno; Tg(KRT14-cre)1Ipc/0 | Pigment cell irregular spatial pattern | ||||||
|
|
|
|
PMID: 23792463, Hyperpigmentation, in combination with Hdac1 ko, Hdac1tm1.1Eno/Hdac1tm1.1Eno; Hdac2tm1.1Eno/Hdac2+, Tg(KRT14-cre)1Ipc/0 (conditional), greater hyperpigmentation in footpads than Hdac1 ko alone | ||||||
|
|
|
Abnormal coat/hair pigmentation, graying seen by P15 on agouti backgound | |||||||
|
|
|
PMID: 16651378, In mouse skin, suppresses graying/melanocyte apoptosis induced by DAPT; Dct-Hes1 transgenic | |||||||
|
|
|
Melanocyte amount ameliorated; suppresses melanoma | |||||||
|
|
|
|
Skin hyperpigmentation, 3 transgenic lines: HGFTg1, HGFTg43 and HGFTg75, hyperpigmentation of line 1 is light, of line 43 moderate and of line 75 dark, most analyses on line 43, PMID: 10842060 | ||||||
|
|
|
Melanocyte differentiation disrupted; eye decreased pigmentation | |||||||
|
|
|
Whole organism pigmentation, abnormal; pigment cell decreased amount | |||||||
|
|
hoxa13a = melanocyte disorganized, abnormal / hoxa13b = melanocyte disorganized, abnormal | ||||||||
|
|
|
Whole organism decreased pigmentation, abnormal | |||||||
|
|
|
HPS1, Hermansky-Pudlak syndrome 1
(#203300) |
Oculocutaneous albinism, hypopigmented hair, freckling and nevi | Decreased ear and tail pigmentation, decreased eye pigmentation, abnormal melanosome morphology, pale ear (ep) | |||||
|
|
|
HPS3, Hermansky-Pudlak syndrome 3
(#614072) |
Oculocutaneous albinism, hypopigmented hair; hypopigmentation of retina and choroid | Diluted coat color, decreased eye pigmentation, abnormal melanosome morphology, cocoa (coa) | |||||
|
|
|
HPS4, Hermansky-Pudlak syndrome 4
(#614073) |
Hypopigmentation of skin and hair, hypopigmentation of retina | Diluted coat color, decreased eye pigmentation, abnormal melanosome morphology, light-ear (le) | |||||
|
|
|
HPS5, Hermansky-Pudlak syndrome 5
(#614074) |
Oculocutaneous albinism, hypopigmented hair | Diluted coat color, abnormal eye pigmentation, abnormal ear pigmentation, ruby-eye2 (ru2) | Iridophore absent; head melanocyte decreased amount; retinal pigmented epithelium decreased pigmentation; retinal pigmented epithelium melanosome decreased amount; retinal pigmented epithelium melanosome immature | ||||
|
|
|
HPS6, Hermansky-Pudlak syndrome 6
(#614075) |
Oculocutaneous albinism, hypopigmented hair | Diluted coat color, abnormal eye pigmentation, abnormal ear pigmentation, ruby-eye (ru) | |||||
|
|
Costello syndrome
(#218040) |
Hyperpigmentation, palmar nevi, congenital melanocytic nevi and blue nevi; also mutated melanocytic nevi | |||||||
|
|
|
Whole organism increased pigmentation | |||||||
|
|
|
PMID: 24024552, Hypopigmented hair in tamoxifen-induced, melanocyte-specific KO, Tyr-cre/ERT2-Hsp90b1flox/flox, (conditional) | |||||||
|
|
|
Pigmentation decreased occurrence | |||||||
|
|
|
Pigment accumulation delayed; trunk melanocyte disorganized | |||||||
|
|
|
KO mice show darkly pigmented dorsal skin and increased melanin content after 10-12 weeks; stems from oxidative damage and upregulated alpha-MSH expression in keratinocytes; PMID: 29660504 | |||||||
|
|
|
Mucopolysaccharidosis type II / Hunter syndrome
(#309900) |
Hyperpigmentation, mongolian spots, retinal pigmentation abnormalities | ||||||
|
|
|
Hurler syndrome
(#607014) |
Hyperpigmentation, mongolian spots | ||||||
|
|
|
Pigmentation delayed; whole organism decreased pigmentation | |||||||
|
|
|
Melanosome transport delayed | |||||||
|
|
|
Melanocyte mislocalised | |||||||
|
|
|
Melanocyte absent, abnormal | |||||||
|
|
|
Melanocyte migration disrupted; melanophore stripe patchy | |||||||
|
|
|
|
Skin morphology alterations; Thickened and hyperpigmented skin, transgenic, Tg(KRT5-IKBKB)1Armz | ||||||
|
|
|
Incontinentia pigmenti
(#308300) |
Hypopigmented skin lesions, hyperpigmented macules in streaky configuration | Skin morphology alterations; Abnormal dermal and epidermal pigmentation, areas of reduced or absent pigmentation, lack of hair growth, increased keratinocyte apoptosis, abnormal kertinocyte morphology | |||||
|
|
|
|
Cell-based phenotype; IL-17 and TNF synergistically inhibited pigmentation-related signaling and melanin production; neutralization of TNF and IL-17 with mAbs resulted in a rapid recovery of pigment gene expression in psoriasis lesions, PMID: 29613836, IL-17 treatment of zebrafish skin inhibits melanogenesis, PMID: 23732752 | ||||||
|
|
|
Hair follicle alterations; Abnormal skin pigmentation, impaired hair follicle morphogenesis, Ilktm1Star/Ilktm1Star; Tg(KRT14-cre)1Amc/0 (conditional) | Pigment cell quality, abnormal | ||||||
|
|
|
Iridophore absent; xanthophore absent; head melanocyte increased amount, abnormal; pigmentation process quality, abnormal | |||||||
|
|
|
Whole organism pigmented, abnormal | |||||||
|
|
|
Melanosome localization disrupted | |||||||
|
|
|
Melanosome transport increased duration, abnormal; whole organism decreased pigmentation | |||||||
|
|
|
Melanosome transport affected; PMID: 18056639 | |||||||
|
|
Skin/hair/eye pigmentation, variation in, SHEP8
(#611724) |
Functionally regulates pigment variation regulation, cooperates with MITF to regulate expression of TYR | |||||||
|
|
|
Melanocyte melanosome increased distribution, abnormal | |||||||
|
|
|
Whole organism increased pigmentation | |||||||
|
|
|
Melanocyte irregular spatial pattern | |||||||
|
|
Skin morphology alterations; Abnormal skin pigmentation, abnormal dermal pigmentation, hypopigmentation, altered skin morphology described by publications, Itgb1tm1Ref/Itgb1tm1Ref; Tg(KRT5-cre)5132Jlj/0 (conditional) | ||||||||
|
|
|
Melanocyte decreased amount; melanophore stripe disorganized | |||||||
|
|
|
Cell-based phenotype; regulates human neural crest specification, knockdown inhibited differentiation of hESC-derived neural crest cells into progeny, including melanocytes | |||||||
|
|
|
Melanophore stripe irregular spatial pattern; melanophore stripe decreased amount; xanthophore spatial pattern, abnormal | |||||||
|
|
kctd15a and kctd15b double mutant = whole organism increased pigmentation, melanocyte increased amount, abnormal | ||||||||
|
|
|
Melanosome localization disrupted | |||||||
|
|
|
Melanocyte black, abnormal; melanocyte melanosome distended, abnormal; whole organism increased pigmentation | |||||||
|
|
|
Cell-based phenotype; si KD blocks melanosome maturation and reduces melanin content; PMID: 26725201 | |||||||
|
|
Piebaldism
(#172800) |
White forelock; hypopigmentation of medial forehead, eyebrows, chin, ventral chest, abdomen, limbs; hyperpigmented borders of unpigmented areas; heterochromia irides | Absent coat pigmentation, diluted coat color, abnormal skin pigmentation, abnormal eye pigmentation, dominant spotting (W) | kita = melanoblast decreased amount; melanocyte decreased size; melanoblast transient increased amount, abnormal; melanocyte spatial pattern, abnormal; melanocyte apoptotic (many other melanocyte phenotypes) | |||||
|
|
|
Familial progressive hyperpigmentation with or without hypopigmentation
(#145250) |
Hyperpigmented and hypopigmented skin patches | Absent coat pigmentation, abnormal skin pigmentation, decreased tail pigmentation, abnormal eye pigmentation, steel (Sl) | Melanocyte decreased amount; melanocyte apoptotic; whole organism lacks all parts of type melanocyte | ||||
|
|
|
Hyperpigmentation; abnormal melanocyte morphology, melanocyte proliferation, increased melanoma incidence in ko mice; Krastm4Tyj/Kras+; Tg(Tyr-cre/ERT2)13Bos/0 (conditional) | |||||||
|
|
|
|
Skin morphology alterations; Hyperpigmentation, abnormal skin pigmentation, hyperkeratosis | ||||||
|
|
|
|
Skin morphology alterations; Increased pigmentation of ear, foot pad and tail, hyperkeratosis | ||||||
|
|
|
|
Skin morphology alterations; Diluted coat color, heterozygotes have a bright coat color apparent at 4 weeks of age, but less obvious at later time points, abnormal skin pigmentation, abnormal epithelial proliferation | ||||||
|
|
|
Dowling-Degos disease 1
(#179850) Epidermolysis bullosa simplex (#131800) |
Dowling-Degos disease 1, Progressive reticulate hyperpigmentation; Epidermolysis bullosa simplex, discrete 2 to 5-mm hyper- and hypopigmented macules, mottled pigmentation of the trunk and proximal extremities | ||||||
|
|
|
|
Skin morphology alterations; Hyperpigmentation on footpads, abnormal epidermis stratum spinosum morphology | ||||||
|
|
|
|
Naegeli-Franceschetti-Jadassohn syndrome
(#161000) Dermatopathia pigmentosa peticularis (#125595) |
Reticulate pattern of hyperpigmentation in both diseases | |||||
|
|
|
|
Hair follicle alterations; Abnormal hair follicle melanin granule morphology, hair follicle degeneration | ||||||
|
|
|
|
Hair follicle alterations; Abnormal hair shaft morphology, "both medulla and cortex have areas of dense pigmentation; where medullary structures break down, pigment aggregates on cortical ridges or is scattered" | ||||||
|
|
|
|
Skin morphology alterations; Integument, heavily pigmented and mildly to non-pigmented hair shafts have defects ranging from loose irregular aggregation of pigment, clumping of pigment within the medulla, clumping with focal distention of the shaft, segregation of pigment with a light brown colored medullary abnormality, to breaking of the hair in the middle of these deformities | ||||||
|
|
|
|
Skin morphology alterations; Increased foot pad and tail pigmentation, abnormal epidermal layer morphology | ||||||
|
|
|
Melanocyte amount, ameliorated | |||||||
|
|
|
Absent hair follicle melanin granule, PMID: 7958926; at P3, mutant hair follicles lack melanin granules, however, both epidermal and dermal melanocytes are present, suggesting melanin absence is secondary to arrest in hair follicle development | Melanocyte decreased amount; whole organism decreased pigmentation | ||||||
|
|
|
Head xanthophore decreased amount; head melanocyte decreased amount; trunk melanocyte decreased amount; trunk xanthophore decreased amount | |||||||
|
|
|
Whole organism decreased pigmentation | |||||||
|
|
|
Eye degree of pigmentation, abnormal; whole organism increased pigmentation | |||||||
|
|
Hair follicle alterations; Abnormal hair shaft melanin granule, irregular melanin piles | ||||||||
|
|
|
Melanocyte dispersed, abnormal | |||||||
|
|
|
Skin morphology alterations; Abnormal epidermal melanocyte morphology, sparse and gray coat in hets, disheveled hair and ears | |||||||
|
|
|
Belly spot, white spotting, belt, dreher (dr) | |||||||
|
|
|
Pigment cell spatial pattern, abnormal | |||||||
|
|
|
OCA7, Oculocutaneous albinism 7
(#615179) |
Hypopigmentation of hair, skin, and irides, hypopigmented retina; freckling | Melanocyte migration disrupted; melanocyte decreased amount; epidermis blistered; whole organism decreased pigmentation | |||||
|
|
|
Whole organism decreased pigmentation | |||||||
|
|
|
Eye iridophore decreased amount; iridophore displaced to trunk; iridophore irregular spatial pattern; melanocyte decreased amount; melanophore stripe spotted, abnormal; trunk melanocyte decreased amount; trunk melanocyte mislocalised | |||||||
|
|
|
|
Cat mutation; darkened coat color, large blotches | ||||||
|
|
|
Chediak-Higashi syndrome
(#214500) |
Skin and hair hypopigmentation; iris hypopigmentation | Diluted coat color, decreased eye pigmentation, abnormal melanocyte morphology, beige (bg) | |||||
|
|
|
Whole organism decreased pigmentation | |||||||
|
|
|
Hypopigmentation, belly spot, dorsal hypopigmentation | |||||||
|
|
|
Cell-based phenotype; KD decreases melanogenesis; upregulates melanogenesis by increasing ERK-dependent MITF expression; autophagy-related, PMID: 26814135 | |||||||
|
|
|
Cell-based phenotype; increased melanosome transport in Xenopus cells; melanophore treatment with U0126 (inhibitor of the upstream ERK kinase MEK) prevented aggregation; also, constitutively active forms of Map2k1 increased aggregation; PMID: 15753041 | |||||||
|
|
|
Cell-based phenotype; increased melanosome transport; melanophores were treated with U0126, a potent inhibitor of the upstream ERK kinase known as MEK, & this prevented aggregation; also, constitutively active forms of Map2k2 increased aggregation, PMID: 15753041 | |||||||
|
|
|
Whole organism pigmented, abnormal | |||||||
|
|
|
Pigment cell spatial pattern, abnormal; pigmentation process quality, abnormal | |||||||
|
|
|
Eye decreased pigmentation; whole organism decreased pigmentation | |||||||
|
|
|
Abnormal coat/hair pigmentation, hypopigmentation, gray coat, woodrat | |||||||
|
|
|
Variation of Skin/hair/eye pigmentation 2
(#266300) Blond hair/fair skin, red hair/fair skin, also modifier of Albinism, oculocutaneous, type II |
Red hair/fair skin, blond hair/fair skin freckles | Abnormal melanogenesis, darkened coat, yellow coat color, recessive yellow (e) | Melanocyte dispersed, abnormal; pigmentation delayed, abnormal; melanocyte decreased amount | ||||
|
|
|
Glucocorticoid deficiency (GCCD1), due to ACTH unresponsiveness
(#202200) |
Hyperpigmentation of skin | ||||||
|
|
|
|
|
KO causes reduced melanin concentration for background color adaptation; PMID: 33301440 | |||||
|
|
|
Abnormal coat/hair pigmentation, slight graying sometimes observed in moribund animals | |||||||
|
|
|
Immunodeficiency-54
(#609981) |
Hyperpigmentation of skin | ||||||
|
|
Diluted coat color, belly spot, varitint waddler (Va) | ||||||||
|
|
|
Melanosome assembly "transport phenotype" delayed | |||||||
|
|
|
Increased foot pad and tail pigmentation | |||||||
|
|
|
Increased foot pad and tail pigmentation | |||||||
|
|
|
Melanocyte quality, abnormal | |||||||
|
|
|
Pigment cell irregular spatial pattern, abnormal | |||||||
|
|
|
Melanocyte morphology, abnormal | |||||||
|
|
|
Melanocyte decreased amount; melanocyte decreased size | |||||||
|
|
Regulates melanocyte development, neural crest-specific knockout shows reduced melanocytes at birth, reduced melanosomes, Mef2cflox/–; Wnt1-CreTg/0 (conditional); PMID: 21610032 | ||||||||
|
|
|
Abnormal coat/hair pigmentation, alopecia, gray hair in tamoxifen-treated mice (ages 2 wk and 14 wk) Memo1tm1.1Neh/Memo1tm1.1Neh; Tg(CAG-cre/Esr1*)1Lbe/0 (conditional) | |||||||
|
|
|
Multiple endocrine neoplasia 1
(#131100) |
Cafe-au-lait macules, confetti-like hypopigmented macules | ||||||
|
|
|
Melanocyte decreased amount; melanocyte position, abnormal; trunk melanophore stripe malformed; xanthophore decreased amount; xanthophore spatial pattern, abnormal | |||||||
|
|
mepce = melanocyte amount, ameliorated | ||||||||
|
|
|
|
|
Quadruple mutant, mespaa, mespab, mespba, mespbb = larval melanophore stripe spatial pattern, abnormal, iridophore patchy, abnormal | |||||
|
|
|
|
|
Quadruple mutant, mespaa, mespab, mespba, mespbb = larval melanophore stripe spatial pattern, abnormal, iridophore patchy, abnormal | |||||
|
|
Quadruple mutant, mespaa, mespab, mespba, mespbb = larval melanophore stripe spatial pattern, abnormal, iridophore patchy, abnormal | ||||||||
|
|
|
Gray coat color, loss of pheomelanin band color, grizzled (gr) | |||||||
|
|
Darkened coat color, increased ear pigmentation, abnormal dermal pigmentation, increased foot pad and tail pigmentation, hyperpigmentation, mahoganoid (md) | ||||||||
|
|
|
Melanocyte irregular spatial pattern; trunk melanocyte absent | |||||||
|
|
Waardenburg syndrome type 2A
(#193510) Tietz albinism-deafness syndrome (#103500) |
Waardenburg syndrome 2A, congenital partial albinism on face, trunk, and limbs, hypopigmented forelock, eyebrows, and eyelashes; heterochromia irides; Tietz albinism-deafness syndrome, fair skin, white eyelashes, eyebrows, and white-blond hair | Absent coat pigmentation, white spotting, belly spot, abnormal eye pigmentation, microphthalmia (mi) | mitfa = eye iridophore absent; iridophore absent; melanocyte absent; pigment cell decreased amount; xanthophore decreased amount | |||||
|
|
|
Melanosome transport delayed | |||||||
|
|
|
Diluted coat color with age, changing from black to "brighter" color (brownish) | |||||||
|
|
|
Diluted coat color | |||||||
|
|
|
Mismatch repair cancer syndrome
(#276300) |
Hyperpigmentation; cafe au lait spots; axillary freckling | ||||||
|
|
Griscelli syndrome 3 | Skin hypopigmentation; silver-gray hair | Diluted coat color, dark gray coat, leaden (ln) | mlpha = pigment granule dispersal arrested; melanocyte melanosome aggregated, abnormal | |||||
|
|
|
Melanocyte spatial pattern, abnormal | |||||||
|
|
|
Pigmentation decreased occurrence | |||||||
|
|
|
Eye pigmentation disrupted; melanocyte differentiation delayed; retinal pigmented epithelium patchy | |||||||
|
|
|
Abnormal coat hair pigmentation, gray at 5 to 6 months, mitochondrial depletion syndrome | Eye iridophore decreased amount; integument translucent, abnormal; melanophore stripe morphology, abnormal; melanocyte decreased amount; pigment cell quality, abnormal | ||||||
|
|
|
Abnormal coat/hair pigmentation, pigment in hair follicles changes from black to light brown | |||||||
|
|
|
Glucocorticoid deficiency 2
(#607398) |
Hyperpigmentation of skin | ||||||
|
|
|
|
Suppresses pigment dilution phenotype, dilute suppressor | ||||||
|
|
|
Mismatch repair cancer syndrome 2 (MMRCS2)
(#619096) |
Hyperpigmentation; cafe au lait spots; axillary freckling | ||||||
|
|
|
Mismatch repair cancer syndrome 3 (MMRCS3)
(#619097) |
Hyperpigmentation; cafe au lait spots; axillary freckling | ||||||
|
|
|
Melanocyte decreased amount | |||||||
|
|
|
Belly spot, variable spotting, Myctm2Fwa/Myctm2Fwa; H2afvTg(Wnt1-cre)11Rth/0 (conditional) | |||||||
|
|
|
Pigmentation process quality, abnormal; xanthophore decreased pigmentation; xanthophore pigment granule condensed | |||||||
|
|
|
Pigmentation disrupted | |||||||
|
|
Griscelli syndrome 1
(#214450) |
Skin and hair hypopigmentation, silver-gray hair | Diluted coat color, dilute (d) | ||||||
|
|
Cell-based phenotype; regulates actin dynamics, biogenesis of melanosomes; KD increases melanin in melanosomes; regulates delivery of Tyrp1, PMID: 22321127 | ||||||||
|
|
|
White spotting | |||||||
|
|
|
Cell-based phenotype; in RPE cells, regulates melanosome motility; localizes to melanosomes; limited melanosome movement in wild-type RPE cells transduced with adenovirus carrying specific sequences to knockdown Myrip expression; part of Rab27a–Myrip–MyoVIIa complex, PMID: 11964381, PMID: 17451552 | |||||||
|
|
|
Belly spot, decreased tail pigmentation, PMID: 24721909 | |||||||
|
|
|
Whole organism decreased pigmentation | |||||||
|
|
|
Nijmegen breakage syndrome
(#251260) |
Café au lait spots, hypopigmented spots | ||||||
|
|
|
Pigment cell quality, abnormal | |||||||
|
|
NF1, neurofibromatosis type 1
(#162200) |
Cafe au lait spots and freckling | Increased ear, foot pad and tail pigmentation, decreased eye pigmentation | nf1a = lateral larval melanophore stripe melanocyte spatial pattern, abnormal / nf1b = lateral larval melanophore stripe melanocyte spatial pattern, abnormal | |||||
|
|
|
|
Cell-based phenotype in mouse mutant; knockout in hair follicle stem cells ectopic, differentiated melanocytes, but no hair graying b/c stem cells maintained | ||||||
|
|
|
Melanosome transport delayed | |||||||
|
|
|
Glucocorticoid deficiency 4, with or without mineralocorticoid deficiency
(#614736) |
Hyperpigmentation of skin | ||||||
|
|
|
Melanocyte spatial pattern, abnormal | |||||||
|
|
Diluted coat color, dispersed gray hairs, in combination with Notch2, Notch1tm1Agt/Notch1tm1Agt; Tg(Tyr-cre)2Lru/0 (conditional) | ||||||||
|
|
|
Diluted coat color, dispersed gray hairs, more extensive in combination with Notch1, Notch2tm1Frad/Notch2tm1Frad; Tg(Tyr-cre)2Lru/0 (conditional) | |||||||
|
|
|
Melanocyte displaced to neural tube ventral surface, abnormal; melanocyte distended | |||||||
|
|
|
Adrenal hypoplasia congenita
(#300200) |
Adrenal insufficiency leading to hyperpigmentation | ||||||
|
|
|
Pigmentation delayed; whole organism increased pigmentation under visual background adaptation (VBA) assay | |||||||
|
|
|
Horse mutation; premature hair graying and melanoma susceptibility, may be combined effect of STX17 and NR4A3, or effect of one of these genes | |||||||
|
|
|
Melanocyte decreased amount; whole organism decreased pigmentation; trunk neural crest cell decreased amount | |||||||
|
|
|
Melanocytic nevus syndrome, congenital, somatic
(#137550) Neurocutaneous melanosis, somatic (#249400) |
Multiple, large, congenital melanocytic nevi | Hyperpigmentation, Nrastm1Tyj/Nrastm1Tyj; Tg(Tyr-cre/ERT2)1Lru/0 (conditional) | |||||
|
|
|
Skin morphology alterations; Irregular coat pigmentation, striped coat, hyperkeratotic plaques | |||||||
|
|
nsfa = melanocyte dispersed, abnormal / nsfb = retinal pigmented epithelium decreased pigmentation; whole organism decreased pigmentation | ||||||||
|
|
|
Abnormal coat/hair pigmentation, gray hair, abnormal skin pigmentation in tamoxifen-treated Nsmce2tm2.1Ofc/Nsmce2tm2.1Ofc; Ndor1Tg(UBC-cre/ERT2)1Ejb/0 (conditional), PMID: 26443207 | |||||||
|
|
|
Melanocyte quality, abnormal | |||||||
|
|
|
Abnormal coat/hair pigmentation, abnormal retinal pigment epithleium morphology, hair growth looks delayed, older mice with white hair tips | |||||||
|
|
|
OCA2, Oculocutaneous Albinism Type II, Brown oculocutaneous albinism, regulates variation of Skin/hair/eye pigmentation 1, blond/brown hair, blue/nonblue eyes
(#203200) |
Hypopigmentation of skin, hair, irides | Diluted coat color, decreased eye pigmentation, pink-eyed dilution (p) | Melanocyte decreased amount; melanocyte melanosome decreased amount; melanocyte melanosome immature, abnormal; whole organism decreased pigmentation | ||||
|
|
|
Eye decreased pigmentation; melanocyte melanosome spatial pattern, abnormal; whole organism decreased pigmentation; melanosome localization disrupted | |||||||
|
|
|
Transverse fur striping, zigzag hairs are abnormally thin, slightly wavy, and have melanin clumps, wavy tiger | |||||||
|
|
|
Pigment cell decreased perimeter, abnormal; pigment cell cell projection increased amount, abnormal | |||||||
|
|
|
Abnormal coat/hair pigmentation, agouti coat appears gray, grey-lethal (gl) | |||||||
|
|
|
Pigmentation decreased occurrence | |||||||
|
|
|
Axis xanthoblast mislocalised medially; axis melanoblast mislocalised medially | |||||||
|
|
|
|
|
pigment cell quality, abnormal; whole organism decreased pigmentation | |||||
|
|
pafah1b1a = pigment cell morphology, abnormal / pafah1b1b = pigment cell morphology, abnormal | ||||||||
|
|
|
Phenylketonuria
(#261600) |
Hypopigmented skin and hair | Hypopigmentation, diluted coat color | |||||
|
|
|
Eye pigmented, abnormal; melanocyte pigment granule decreased amount; iridophore pigment granule decreased amount; xanthophore absent | |||||||
|
|
|
Melanocyte decreased amount; melanocyte neural crest cell migration process quality, abnormal; pigmentation decreased process quality, abnormal | |||||||
|
|
|
Fanconia anemia FANCN
(#610832) |
Hyperpigmentation; cafe au lait spots | ||||||
|
|
|
Cell-based phenotype; hypopigmentation, mediates progesterone steroid effects on human pigment synthesis; shown in vitro and in organotypic skin tissue, PMID: 27115344 | |||||||
|
|
Increased melanoma/metastasis formation (chemical induction with DMBA/TPA) | ||||||||
|
|
|
Dyskeratosis congenita DKCB6
(#616353) |
Abnormal skin pigmentation | ||||||
|
|
|
Pigmentation decreased occurrence | |||||||
|
|
Waardenburg syndrome 1
(#193500) Waardenburg syndrome 3 (#148820) |
Hypopigmented skin regions on face trunk and limbs; hypopigmented forelock, eyebrows, and eyelashes; premature graying; heterochromia irides; hypopigmented irides | Belly spotting, diluted coat color, absent skin pigmentation, splotch (Sp) | pax3a = xanthophore decreased amount; melanoblast decreased amount; melanocyte differentiation delayed; trunk melanocyte mislocalised | |||||
|
|
pax7a/pax7b double mutants = developmental pigmentation disrupted; development of xanthophores disrupted; increased melanophores in development and adults | ||||||||
|
|
|
Belly spot, hypopigmentation (10%) | |||||||
|
|
|
Reduction causes defects in melanoblast and melanocyte migration, PMID: 29604249 | |||||||
|
|
|
|
|
In pcdh10a ko, pcdh10b is upregulated; kd of both in melanocytes causes more severe melanocyte defects than in just pcdh10a alone, PMID: 29604249 | |||||
|
|
|
Microcephalic osteodysplastic primordial dwarfism type II
(#210720) |
Hyperpigmentation and hypopigmentation; café au lait spots | ||||||
|
|
|
Melanocyte melanosome spatial pattern, abnormal; melanocyte increased area, abnormal; cellular pigment accumulation arrested | |||||||
|
|
|
Abnormal agouti pigmentation, dark‐like (dal) | |||||||
|
|
|
Belly spot, white tail tip | |||||||
|
|
Diluted coat color, gray, Gt(ROSA)26Sortm1(cre/ERT2)Thl/0; Picalmtm1.1Tmae/Picalmtm1.1Tmae (conditional) | ||||||||
|
|
|
Melanocyte area, abnormal; melanocyte increased size, abnormal; pigmentation process quality, abnormal | |||||||
|
|
|
PMID: 29584722, coat color dilution, PIKfyveFlox/Flox; TyrCreERT2 (conditional), melanocyte-specific KO mice show graying (C57Bl6 background), regulates melanosome trafficking | |||||||
|
|
Melanocyte decreased amount, abnormal | ||||||||
|
|
|
Melanocyte spatial pattern, abnormal | |||||||
|
|
|
|
|
Xanthophore carotenoid vesicle aggregated, abnormal | |||||
|
|
|
Head melanocyte increased amount; cellular response of melanocyte constriction to light stimulus abnormal | |||||||
|
|
|
Belly spot, abnormal coat/hair pigmentation | |||||||
|
|
|
pmch expression changes in brain correlate with skin pigment levels; is a key regulator of food intake and energy homeostasis in mammals, but regulates pigment aggregation/coloration in teleosts (most ray-finned fish), PMID: 19827161, Overexpression causes impaired melanin concentration for background color adaptation, PMID: 33301440 | Cell-based phenotype; functions to modulate aMSH in human skin, PMID: 12176038 | ||||||
|
|
|
|
|
Overexpression causes impaired melanin concentration for background color adaptation, PMID: 33301440 | |||||
|
|
Abnormal tail pigmentation; abnormal choroid melanin granule morphology; abnormal retinal melanin granule morphology, silver (si) | pmela = melanocyte aggregated, abnormal; melanocyte decreased pigmentation; retinal pigmented epithelium melanosome decreased amount / pmelb = melanosome localization process quality, abnormal; retinal pigmented epithelium melanosome decreased amount | |||||||
|
|
|
Mismatch repair cancer syndrome 4 (MMRCS4)
(#619101) |
Hyperpigmentation; cafe au lait spots; axillary freckling | ||||||
|
|
|
Melanophore stripe decreased thickness; pigmentation disrupted | |||||||
|
|
|
Melanocyte mislocalised | |||||||
|
|
|
Dowling-Degos disease 2
(#615327) |
Reticular hyperpigmentation and hypopigmentation of the flexures | Whole organism axis decreased pigmentation | |||||
|
|
|
Dowling-Degos disease 4
(#615696) |
Hyperpigmentation; macular and lentiginous lesions; hyperpigmentation at rete ridges | ||||||
|
|
|
Melanocyte decreased amount, abnormal | |||||||
|
|
|
Pigmentary disorder, reticulate, with systemic manifestations, X-linked
(#301220) |
Reticulate skin hyperpigmentation | ||||||
|
|
|
Premature graying | |||||||
|
|
|
Xeroderma pigmentosum XPV
(#278750) |
Pigmented or depigmented macules and patches | Abnormal ear pigmentation upon UV exposure | |||||
|
|
|
Melanocyte quality, abnormal | |||||||
|
|
|
Trunk decreased pigmentation | |||||||
|
|
Obesity, adrenal insufficiency, and red hair due to POMC deficiency
(#609734) |
Pale skin, red hair | Yellow coat color, diluted coat color | pomca = melanocyte melanosome aggregated, abnormal; melanosome localization disrupted | |||||
|
|
|
|
|
Hyperpigmentation with age for tails, paws and snout | |||||
|
|
|
Overexpression induces pigmentation in melanocyte-specific transgenic mice (darkens the fur of Ay/a mice) and also in cell culture, Tyr::rtTA; TetO::PGC-1α transgenics; PMID: 23201126 | |||||||
|
|
|
Pigment cell decreased amount | |||||||
|
|
|
Iridophore decreased pigmentation; melanocyte decreased pigmentation; melanocyte irregular spatial pattern; xanthophore decreased pigmentation | |||||||
|
|
|
KD of prickle2b suppresses bbs7 mutant-related melanosome transport delay; PMID: 24938409 | |||||||
|
|
Carney complex 1 (CNC1)
(#160980) |
Hyperpigmentation, profuse pigmented lesions, nevi, lentigines, ephelides | |||||||
|
|
|
Hyperpigmentation of footpad and tail | |||||||
|
|
prps1a = iridophore decreased amount; retinal pigmented epithelium decreased thickness; yolk iridophore decreased amount / prps1b = eye decreased pigmentation; eye iridophore decreased amount; yolk iridophore decreased amount | ||||||||
|
|
|
Trunk melanocyte decreased amount; melanocyte spatial pattern, abnormal | |||||||
|
|
|
Trunk melanocyte decreased amount; melanocyte spatial pattern, abnormal | |||||||
|
|
|
Acne inversa, familial, 2, with or without Dowling-Degos disease
(#613736) |
Reticulate hyperpigmentation in flexural areas, face, trunk, and neck | Pigment cell decreased amount | |||||
|
|
|
Belly spot | Pigment cell decreased amount | ||||||
|
|
|
Pigment cell decreased amount; retinal pigmented epithelium displaced, abnormal | |||||||
|
|
Bannayan-Riley-Ruvalcaba syndrome, Cowden syndrome
(#158350) |
Hyperpigmentation; lentigines, cafe au lait spots | Hyperpigmentation, Ptentm1Hwu/Ptentm1Hwu; Tg(Tyr-cre)1Lru/0 (conditional) | ||||||
|
|
|
Abnormal skin pigmentation, focal depigmentation secondary to immune system affects | |||||||
|
|
|
LEOPARD syndrome 1
(#151100) |
Multiple lentigines, cafe au lait spots, darkly pigmented spots | Abnormal melanocyte morphology, reduced number, Ptpn11tm1.1Wbm/ Ptpn11tm1.1Wbm; H2afvTg(Wnt1-cre)11Rth/0 (conditional) | Melanocyte decreased amount; melanocyte mislocalised | ||||
|
|
|
Melanocyte mislocalised | |||||||
|
|
|
Diluted coat color, light hair, and sparse hair | |||||||
|
|
|
Belly spot | |||||||
|
|
|
Cell-based phenotype; functional ablation induced perinuclear melanosome aggregation; long-range anterograde melanosome movements were suppressed in Rab1A-deficient melanocytes, PMID: 22854043 | |||||||
|
|
|
Melanosome transport decreased rate | |||||||
|
|
|
Cell-based phenotype; regulates TYRP1 trafficking and melanosome transport, PMID: 16965270; PMID: 21352276; is a lineage-specific melanoma driver, but no pigmentation correlation seen; PMID: 24981740 | |||||||
|
|
|
Injection of Rab8[T22N] mutation impacts melanosome transport time, PMID: 17574030 | |||||||
|
|
|
Cell-based phenotype; KD in melanocytes leads to loss of pigment; PMID: 26527546 | |||||||
|
|
|
Melanosome transport decreased rate | |||||||
|
|
|
Cell-based phenotype; mediates melanosome transfer to keratinocytes, siRNA reduces keratinocyte-stimulated melanin release from melanocytes; PMID: 24141907 | |||||||
|
|
|
|
Cell-based phenotype; Rab17 KD caused marked accumulation of melanosomes at the periphery, particularly in dendrites; also caused melanin accumulation, PMID: 21291502 | ||||||
|
|
Griscelli syndrome 2
(#607624) |
Skin hypopigmentation; silver-gray hair | Diluted coat color, abnormal melanosome transport, hypopigmentation, ashen (ash) | ||||||
|
|
|
Cell-based phenotype; knockdown in Rab38-deficient cht cells causes loss of pigmentation, thus Rab32 and Rab38 function together to regulate pigmentation and melanogenic enzyme trafficking; PMID: 17043139 | |||||||
|
|
|
Cell-based phenotype; regulates retrograde melanosome transport in melanocytes, PMID: 22740695 | |||||||
|
|
|
Diluted coat color, abnormal eye pigmentation, chocolate (cht) | |||||||
|
|
Diluted coat color, gunmetal (gm) | ||||||||
|
|
Skin morphology alterations; Abnormal skin pigmentation, white spotting, gray coat with progressive loss of hair, abnormal skin physiology, Rac1tm1Brak/ Rac1tm1Brak; Tg(KRT5-cre)5132Jlj/0 (conditional) | ||||||||
|
|
|
Belly spot, decreased foot and tail pigmentation | |||||||
|
|
|
Melanocyte mislocalised | |||||||
|
|
|
Hyperpigmentation, increased foot pad and tail pigmentation | |||||||
|
|
|
Iridophore decreased pigmentation; xanthophore decreased pigmentation | |||||||
|
|
Noonan syndrome 5
(#611553) |
Lentigines, café au lait spots | |||||||
|
|
|
Hypopigmentation of skin and hair, immune-related vitiligo after transplant of CD4-selected splenocytes | |||||||
|
|
|
Cell-based phenotype; in B16 melanoma cells, melanin production is inhibited in forskolin-stimulated cells; also inhibits dendrite formation & proliferation & promotes apoptosis; PMID: 16272156 | |||||||
|
|
|
Belly spot, decreased melanocyte cell number at E14.5, Raph1tm1.1Makr/Raph1tm1.1Makr; Tmem163Tg(ACTB-cre)2Mrt/0; Tg(Dct-LacZ)A12Jkn/ Tg(Dct-LacZ)A12Jkn (conditional) | |||||||
|
|
|
Melanosome localization disrupted; retinal pigmented epithelium quality, abnormal | |||||||
|
|
|
Abnormal melanocyte morphology, melanocyte growth defects, Rb1tm1.1Gfk/Rb1tm1.1Gfk; Tg(Tyr-cre)1Gfk/0 (conditional) | Melanocyte area, abnormal | ||||||
|
|
Diluted coat color, almost complete hair whitening interspersed with black hairs to produce gray coat, Rbpjtm1Hon/Rbpjtm1Hon; Tg(Tyr-cre)2Lru/0 (conditional) | ||||||||
|
|
|
Rothmund-Thomson syndrome type 2
(#268400) |
Premature hair graying, in context of premature aging | Skin morphology alterations; Absent coat pigmentation, patches of colorless hair in 65% of mice, alopecia with hair loss encompassing ~20% of body surface | |||||
|
|
|
Belly spot, Restfloxed/+; Wnt1-Cre (conditional); no belly spot seen in other conditional Cre alleles (P0-Cre, K14-Cre, Dct-Cre or Tyr-Cre), PMID: 25818501 | |||||||
|
|
|
Keratinocyte-specific KO increased pigmentation in mouse skin in response to UV and wound healing; PMID: 30046772 | |||||||
|
|
|
|
Hair follicle alterations; Abnormal hair shaft melanin granule; "A few tapered ends protrude only a short distance out of the hair shaft. The shafts generally lack hair cells and contain only irregular melanin granules," curly bare | ||||||
|
|
|
Melanocyte irregular spatial pattern; trunk melanocyte aggregated, abnormal; trunk decreased pigmentation | |||||||
|
|
|
Cell-based phenotype; regulates melanosome transport; KD is phenocopy of melanoregulin kd in ashen cells; melanoregulin regulates retrograde melanosome transport by interaction with the RILP–p150Glued complex in melanocytes--phenocopy seen for KD of RILP, DCTN1 (p150Glued), and overexpression of DCTN2, PMID: 22275436 | |||||||
|
|
|
Noonan Syndrome 8
(#615355) |
Hyperpigmentation | ||||||
|
|
|
Melanocyte increased branchiness; xanthophore decreased branchiness; xanthophore decreased size | |||||||
|
|
|
Melanocyte decreased amount | |||||||
|
|
rpgrb = pigment granule aggregation in cell center delayed, abnormal | ||||||||
|
|
|
Belly spot, white spotting, belly spot and tail (Bst) | |||||||
|
|
|
Hyperpigmentation of footpad, ear, and tail | |||||||
|
|
|
Belly spot, background sensitivity: white hairs on front legs that look like white stockings, Tail short (Ts) | |||||||
|
|
|
PMID: 18641651, Hyperpigmentation in keratinocyte-specific KO, Rps6lox/+; Tg.K5Cre/+ (conditional); hypopigmentation in melanocyte-specific KO, Rps6lox/+; Tg.MitfCre/+ (conditional) | |||||||
|
|
|
Belly spot, montu (Mtu) | |||||||
|
|
|
Pigmentation delayed | |||||||
|
|
|
Hyperpigmentation, abnormal skin pigmentation, increased foot pad and tail pigmentation | |||||||
|
|
|
Abnormal skin pigmentation, increased foot pad pigmentation, PMID: 18641651 | |||||||
|
|
|
Melanocyte melanosome decreased pigmentation | |||||||
|
|
|
Belly spot | |||||||
|
|
|
Hair follicle alterations; Diluted coat color, alopecia, premature graying, abnormal melanosome morphology, Rxratm2Ipc/Rxratm4Ipc; Tg(KRT14-cre)1Ipc/0 (conditional), also abnormal retinal pigmentation, Rxratm4Ipc/Rxratm4Ipc; Tg(Tyrp1-cre)1Ipc/0 (conditional) | |||||||
|
|
|
|
|
Mirage syndrome
(#617053) |
Hyperpigmentation, reflective of adrenal insufficiency | ||||
|
|
Dyschromatosis universalis hereditaria-1 (DUH1)
(#127500) |
PMID:25315659, PMID:26203640, PMID: 27659786, Hyperpigmentation and hypopigmentation; reticulate hypopigmentation and hyperpigmentation; hypo- and hyperpigmented macules; lentiginosis | |||||||
|
|
|
Melanocyte quality, abnormal; trunk decreased pigmentation | |||||||
|
|
|
|
|
Whole organism increased pigmentation | |||||
|
|
|
Melanocyte irregular spatial pattern; melanocyte morphology, abnormal | |||||||
|
|
|
Pigmentation decreased occurrence, abnormal | |||||||
|
|
|
Melanocyte differentiation disrupted, abnormal; melanocyte decreased amount, abnormal | |||||||
|
|
|
Whole organism degree of pigmentation, abnormal | |||||||
|
|
|
Belly spot | |||||||
|
|
|
Melanocyte differentiation disrupted | |||||||
|
|
|
Pigmentation process quality, abnormal | |||||||
|
|
|
|
Fewer melanocytes in skin when sFRP4 protein overexpressed in mouse skin by adenovirus infection; sFRP4 normally secreted by keratinocytes, downregulates WNT signaling, prevents melanocyte differentiation, PMID: 28337220 | ||||||
|
|
|
Nephrotic syndrome 14
(#617575) |
Hyperpigmentation, reflective of adrenal insufficiency | ||||||
|
|
|
Cell-based phenotype; regulates trafficking of all 3 melanogenic enzymes; PMID: 26620560 | |||||||
|
|
Cell-based phenotype; si knockdown reduces melanin content, Tyr activity; show Sh3bp4 is directly upregulated by MITF and directly inhibited by miR-125B, PMID: 28819321 | ||||||||
|
|
|
Trunk melanocyte decreased amount | |||||||
|
|
|
Caudal fin melanocyte mislocalised | |||||||
|
|
|
Noonan-like syndrome with loose anagen hair 1
(#607721) |
Skin hyperpigmentation | ||||||
|
|
Xenopus mutation; cell-based melanocye phenotype showing regulation of melanosome biogenesis and localization, and RPE pigmentation defects | ||||||||
|
|
Darkened coat color, brown (agouti-like) hair on the dorsal region and slightly darker hair on ventral region when compared with Ay/a mice | ||||||||
|
|
|
Pigmentation process quality, abnormal | |||||||
|
|
slc2a1a = whole organism decreased pigmentation, abnormal / slc2a1b = whole organism decreased pigmentation, abnormal | ||||||||
|
|
|
|
Xanthophore absent | ||||||
|
|
|
Diluted coat color, graying, yellow hair pigment is reduced, black pigment is unaffected, subtle gray (sut) | |||||||
|
|
|
Pigment cell quality, abnormal | |||||||
|
|
|
Whole organism decreased pigmentation, abnormal | |||||||
|
|
|
Sialic acid storage disorder, infantile
(#269920) |
Hypopigmented skin and hair | ||||||
|
|
|
Pigmentation process quality, abnormal | |||||||
|
|
|
Melanocyte quality, abnormal | |||||||
|
|
|
OCA6, Oculocutaneous albinism, type 6
(#113750) |
Hypopigmented skin, hair, irises | Abnormal coat/hair pigmentation, abnormal dermal pigmentation, abnormal iris pigmentation | Integument melanocyte decreased amount; melanocyte absent; cellular pigmentation process quality, abnormal; retinal pigmented epithelium unpigmented; melanophore stripe decreased; whole organism decreased pigmentation; melanocyte unpigmented | ||||
|
|
|
Histiocytosis-lymphadenopathy plus syndrome
(#602782) |
Skin hyperpigmentation, pigmented hypertrichosis | ||||||
|
|
|
Abnormal coat/hair pigmentation, portions of black, nonagouti hair can show bronzing effect, becoming reddish in patches, abnormal zinc homostasis, lethal-milk (lm) | |||||||
|
|
|
Hypopigmentation, Slc31a1tm2Djt/ Slc31a1tm2Djt, Tg(Vil1-cre)997Gum/0 (conditional), copper transporter | |||||||
|
|
|
Horse mutation; Champagne color, hypopigmentation, dilution of skin, hair, and eye, PMID: 18802473 | |||||||
|
|
|
Eye decreased pigmentation; trunk decreased pigmentation | |||||||
|
|
|
OCA4, Oculocutaneous albinism, type 4, coding region alterations affect variation of Skin/hair/eye pigmentation 5, black/nonblack hair, dark/fair skin, dark/light eyes
(#606574) |
Hypopigmented skin, hair, irides | Abnormal skin pigmentation, hypopigmentation, diluted coat color, abnormal eye pigmentation | Melanocyte decreased pigmentation; melanocyte absent; melanocyte decreased pigmentation; retinal pigmented epithelium unpigmented, abnormal; whole organism colorless; whole organism decreased pigmentation | ||||
|
|
|
PMID: 28431046, white spotting, Smarca4 Mos6/+; Sox10 LacZ/+ double heterozygous mice show synergistic increase in white spotting, also neural crest-specific KO causes melanoblast reduction Smarca4tm1.2Pcn; Tg(SOX10-cre)1Wdr (conditional) | Melanocyte decreased amount; retinal pigmented epithelium decreased pigmentation; whole organism decreased pigmentation | ||||||
|
|
|
PMID: 15890782, PMID: 17450140, heterozygous Smarca5 mutation causes dominant mottled coat with in mice with variegated allele of a, Avy/a, paternal effect, study measuring epigenetic changes/methylation | |||||||
|
|
|
Schimke immunoosseous dysplasia
(#242900) |
Hyperpigmentation, numerous lentigines | ||||||
|
|
|
Melanocyte decreased amount | |||||||
|
|
|
PMID: 15890782, PMID: 18425126, study measuring epigenetic changes at variegated allele of a, Avy, affects percentage of female yellow pups on Avy background, X-inactivation role | |||||||
|
|
|
Curry-Jones syndrome
(#601707) |
Hypopigmented streaky lesions | Caudal fin melanocyte mislocalised | |||||
|
|
|
|
|
Melanosome aggregation; recombinant protein induced melanosome aggregation in a concentration-dependent manner; PMID: 16259984 | |||||
|
|
|
Waardenburg Syndrome 2D
(#608890) Piebaldism (#172800) |
Hypopigmented skin regions on face, trunk and limbs; hypopigmented forelock, eyebrows, and eyelashes; hyperpigmented borders of hypopigmented areas; premature graying; heterochromia iridis | Head blaze, variable body spotting | |||||
|
|
|
Pigmentation disrupted | |||||||
|
|
|
Whole organism decreased pigmentation | |||||||
|
|
|
Inconsistent data: PMID: 15846349, Ysb mutation (complex chromosomal rearrangement caused by transgene insertion upstream of Sox2) was crossed with a Sox2 targeted null; "Similar to Ysb/Ysb and Lcc/Lcc mutants, Ysb/Sox2bgeo compound heterozygotes exhibited yellow coats as well as circling and deafness, indicating non-complementation;" Conversely, PMID: 22186729, Sox2fl/fl; Wnt1Cre mice (conditional) showed increased embryonic melanoblast numbers, but at postnatal (P)5 "revealed no increase in skin color and melanocyte numbers in hair follicles of the back skin" | |||||||
|
|
|
Medaka mutation; melanocyte phenotype, fate switch in pigment cell development, PMID: 24699463 | |||||||
|
|
Diluted coat color, white spotting, Tg(Dct-SOX9)aCeb, transgenic (two lines generated) | sox9a = iridophore decreased amount; melanocyte increased size, abnormal / sox9b = iridophore decreased amount; melanocyte increased size, abnormal | |||||||
|
|
|
Waardenburg syndrome 2E
(#611584) Waardenburg syndrome 4C (#613266) PCWH syndrome (#609136) |
All 3 syndromes show hypopigmented skin regions; hypopigmented forelock, eyebrows, and eyelashes; premature graying, heterochromia irides; bright blue irides; WS2E also reports cafe au lait spots; freckling | Belly spot, diluted coat color, decreased foot and tail pigmentation | Melanocyte decreased amount; pigment cell irregular spatial pattern; xanthophore morphology, abnormal | ||||
|
|
|
Darkened coat color, reduced subapical pheomelanin band | |||||||
|
|
|
Diluted coat color, pale skin | |||||||
|
|
|
Legius syndrome
(#611431) |
Cafe-au-lait spots, axillary freckling | ||||||
|
|
|
Diluted coat color, varies on genetic background | |||||||
|
|
|
Integument pigmentation disrupted; melanophore stripe decreased width; melanophore stripe patchy; integument xanthophore mislocalised | |||||||
|
|
|
Salt and pepper developmental regression syndrome
(#609056) |
Hyperpigmented 2 to 5-mm macules mainly on the extremities, 'salt and pepper' pigmentary changes | ||||||
|
|
|
Lipoid adrenal hyperplasia
(#201710) |
Congenital hyperpigmentation, from intrauterine glucocorticoid deficiency | ||||||
|
|
stim1a = PMID: 29311116, KD reduces melanin content and melanophore pigmentation (melanoblast and melanophore number/location normal) / stim1b = no influence pigmentation | Cell-based phenotype; regulates melanin production; stim1b shown not to influence pigmentation, PMID: 29311116 | |||||||
|
|
|
Peutz-Jeghers syndrome
(#175200) |
Hyperpigmented spots on hands (especially palms), arms, feet (especially plantar areas), legs, and lips | ||||||
|
|
|
Cell-based phenotype; Stx3 regulates melanosomal localization of TYRP1, and KD reduces melanin content; PMID: 23549422 | |||||||
|
|
|
Cell-based phenotype; kd reduces pigmentation of melanocytes in vitro; interacts with VAMP7; regulates cargo delivery from recycling endosomes during melanosome biogenesis, PMID: 26208634 | |||||||
|
|
|
Horse mutation; gray phenotype is caused by a 4.6-kb duplication in intron 6 of STX17; both STX17 and the neighboring NR4A3 gene are overexpressed in melanomas from Gray horses; phenotypes in Gray horses may be caused by overexpression of both STX17 and NR4A3, or of one of these alone, PMID: 18641652 | |||||||
|
|
stxbp1a = whole organism increased pigmentation / stxbp1b = whole organism increased pigmentation | ||||||||
|
|
|
Darkened coat on agouti background, increased pigmentation of tail and paws, ventral alopecia | |||||||
|
|
|
Lateral larval melanophore stripe has fewer parts of type melanocyte | |||||||
|
|
|
Melanocyte decreased amount; whole organism decreased pigmentation | |||||||
|
|
|
Pigmentation process quality, abnormal | |||||||
|
|
Cell-based phenotype; binds RAb27a, required for peripheral melanosome distribution and elongated cell shape in melanocytes; slp2-a = Sytl2 | ||||||||
|
|
|
Diluted coat color | |||||||
|
|
|
Grizzled coat color | |||||||
|
|
|
Melanocyte growth defects, Taf4tm1Idvd/Taf4tm1Idvd; Tg(KRT14-cre/ERT2)1Ipc/0 (conditional) mice show "invasive melanocytic tumors" upon treatment with the mutagen DMBA, PMID: 17626060 | |||||||
|
|
|
Cell-based phenotype; functions as GTPase activating protein for Rab27a and induces melanosome aggregation in mouse melanocytes | |||||||
|
|
|
Cell-based phenotype; functions as GTPase activating protein for Rab27a and induces melanosome aggregation in mouse melanocytes | |||||||
|
|
|
Whole organism degree of pigmentation, abnormal | |||||||
|
|
|
Hypopigmentation, head spot, Dancer (Dc) | |||||||
|
|
|
Abnormal ventral coat pigmentation, "in combination with at and Aw, lighter belly hair comes up farther on the sides and face than patterning of at or Aw", PMID: 14737183, droopy ear (de) mutant | |||||||
|
|
|
Hypopigmentation, abnormal ventral coat pigmentation, yellow ventrum pigmentation, instead of light gray pigmentation in controls | |||||||
|
|
|
Pigment accumulation process quality, abnormal | |||||||
|
|
|
Skin morphology alterations; Hyperpigmentation, Terf1tm1.1Blas/Terf1tm1.1Blas; Tg(KRT5-cre)1Tak/0 | |||||||
|
|
|
K5-Terf2 transgenic, PubMed:16142233, hyperpigmented skin in sun-exposed areas | |||||||
|
|
|
Hyperpigmentation, Terf2iptm1.1Blas/Terf2iptm1.1Blas; Tg(KRT5-cre)1Tak/0 (conditional) | |||||||
|
|
|
Dyskeratosis congenita DKCA2
(#613989) |
Graying hair; reticulated skin hyperpigmentation | ||||||
|
|
|
Pigmentation process quality, abnormal, in combination with tet3 | |||||||
|
|
|
Pigmentation process quality, abnormal, in combination with tet2 | |||||||
|
|
|
Belly spot, abnormal foot and tail pigmentation, Tfap2atm1Hsv/ Tfap2atm2Will; H2afvTg(Wnt1-cre)11Rth/0 (conditional), also abnormal retinal pigment epithelium, Tfap2atm1Will/ Tfap2atm1Will | Melanocyte absent; melanocyte differentiation disrupted; melanocyte pigment granule decreased amount; pigmentation disrupted; retinal pigmented epithelium mislocalised | ||||||
|
|
|
Melanocyte absent | |||||||
|
|
|
Melanocyte differentiation disrupted; melanocyte pigment granule decreased amount | |||||||
|
|
|
Whole organism decreased pigmentation | |||||||
|
|
PMID: 20144786, Graying in mice with melanocyte-specific KO, TGFBRIIfx/fx; Dctcre/cre mice (conditional), ectopic pigmented melanocytes with dendritic morphology | ||||||||
|
|
|
Whole organism decreased pigmentation | |||||||
|
|
|
Dyskeratosis congenita DKCA3
(#613990) |
Graying hair; reticulated skin hyperpigmentation | ||||||
|
|
|
Iridophore structure, abnormal; melanocyte decreased amount; melanophore stripe broken; xanthophore displaced to melanophore stripe | |||||||
|
|
|
Autoinhibition-defective Tln1 mutant mice show belly spots (reduced ventral follicular melanocytes), hypopigmented tail tips and feet; primary mutant melanocytes show greater adhesion, less migration; PMID: 32580934 | |||||||
|
|
|
Whole organism decreased pigmentation | |||||||
|
|
|
Darkened coat color, abnormal digit and footpad pigmentation, increased tail pigmentation | Pigmentation sporadic, abnormal | ||||||
|
|
|
ADULT syndrome
(#103285) |
Hypopigmentation of skin and hair, and hyperpigmentation, intense freckling | ||||||
|
|
|
Coding region alterations affect variation of skin/hair/eye pigmentation 10, blond/brown hair
(#612267) |
Blond/brown hair | Eye decreased pigmentation; trunk decreased pigmentation | |||||
|
|
|
Skin morphology alterations; Abnormal skin pigmentation, lighter skin color at birth, with gradual pigmentation, alopecia, Traf6tm1Jino/ Traf6tm1Jino | |||||||
|
|
|
|
Irregular coat pigmentation, abnormal melanosome morphology, abnormal retinal pigmentation | ||||||
|
|
|
Melanosome transport delayed | |||||||
|
|
|
Iridophore degree of pigmentation, abnormal; iridophore increased amount; iridophore irregular spatial pattern | |||||||
|
|
|
Horse mutant; white spotting and blindness, differential expression in retina and pigmented/unpigmented skin of appaloosa horses; no human dermal pigment phenotype, but causes congenital stationary night blindness | |||||||
|
|
|
PMID: 22203997, hypopigmentation; white hair due to missing melanoblasts/melanocytes seen in neural crest-specific knockout, Trpm7fl/fl; Pax3-Cre (conditional) | Melanocyte colorless; melanocyte differentiation disrupted; melanocyte irregular spatial pattern; melanocyte melanosome malformed | ||||||
|
|
Tuberous sclerosis complex 1
(#191100) |
Hypopigmentation, hypomelanotic macules | |||||||
|
|
|
Tuberous sclerosis complex 2
(#613254) |
Hypopigmentation, hypomelanotic macules | ||||||
|
|
|
In mutation causing constitutive tshr activation, melanocyte decreased amount; xanthophore increased amount; xanthophore differentiation abnormal / in hypomorphic allele, opposite observed (increased melanocytes, decreased xanthophores) | |||||||
|
|
|
|
|
Melanophore stripe irregular spatial pattern; melanocyte decreased cellular motility; melanocyte confluent with xanthophore | |||||
|
|
|
pigmentation disrupted; eye lighter in figure image | |||||||
|
|
|
|
|
Melanocyte quality, abnormal; pigment cell irregular spatial pattern; pigment cell decreased amount | |||||
|
|
|
Melanocyte quality, abnormal; retinal pigmented epithelium quality, abnormal | |||||||
|
|
|
OCA1A, Oculocutaneous albinism, type IA
(#203100) OCA1B, Oculocutaneous albinism type IB (#606952) coding region alterations affect variation of skin/hair/eye pigmentation 3, blue/green eyes, light/dark/freckling skin |
Absence of skin, hair, and iris pigmentation | Absent coat pigmentation, diluted coat pigmentation, abnormal eye pigmentation, albino (c) | Iridophore morphology, abnormal; melanocyte decreased pigmentation; retinal pigmented epithelium melanosome absent | ||||
|
|
OCA3, Oculocutanous albinism, type III, coding region alterations affect variation of skin/hair/eye pigmentation, variation in, 11 (Melanesian blond hair)
(#203290) |
Hypopigmented skin, hair, and irides, in some dark-skinned individuals, bright copper-red coloration of skin and hair and dilution of iris pigmentation | Diluted coat color, abnormal iris pigmentation, decreased eye pigmentation, brown (b) | tyrp1a = melanocyte colorless; retinal pigmented epithelium brown, abnormal; melanocyte melanosome decreased amount / tyrp1b = dermis melanocyte decreased size, abnormal; melanocyte brown, abnormal; retinal pigmented epithelium brown, abnormal | |||||
|
|
|
Melanophore stripe disorganized; melanocyte differentiation delayed | |||||||
|
|
|
Pigmentation decreased occurrence | |||||||
|
|
|
Abnormal dorsoventral coat patterning, dorsal coat darkens from brown to "black hair" and then turns to gray with age | |||||||
|
|
|
Pigmentation process quality, abnormal | |||||||
|
|
|
Abnormal ventral coat pigmentation, 10% of homozygotes have belly spot | |||||||
|
|
|
Pigmentation decreased occurrence | |||||||
|
|
|
Pigmentation decreased occurrence | |||||||
|
|
|
Mental retardation, X-linked 99, syndromic, female-restricted
(#300919) |
Skin pigmentary abnormalities following the lines of Blaschko | ||||||
|
|
|
Pigmentation decreased occurrence | |||||||
|
|
|
Pigmentation decreased occurrence | |||||||
|
|
|
Pigmentation decreased occurrence | |||||||
|
|
|
Pigmentation decreased occurrence | |||||||
|
|
|
Pigmentation decreased occurrence | |||||||
|
|
|
Pigmentation decreased occurrence | |||||||
|
|
|
Pigmentation decreased occurrence | |||||||
|
|
|
Pigmentation decreased occurrence | |||||||
|
|
|
Pigmentation decreased occurrence | |||||||
|
|
|
Morphilno kd causes reduced pigmented melanocytes; PMID: 30061422 | Cell-based phenotype; KO causes hypopigmentation and melanosome mislocalization in cultured B16 cells, stable overexpression causes hyperpigmentation | ||||||
|
|
|
UV-sensitive syndrome 3 (UVSS3)
(#614640) |
Freckling and modest pigmentation anomalies, Xeroderma pigmentosum-like symptoms | ||||||
|
|
|
Whole organism decreased pigmentation | |||||||
|
|
|
Diluted coat color | |||||||
|
|
|
Cell-based phenotype; kd reduces pigmentation of melanocytes in vitro; interacts with STX12; regulated by BLOC-1 and BLOC-3 and cycles to and from melanosomes to aid in trafficking and secretion of pigment enzymes, PMID: 27482051, PMID: 26208634 | |||||||
|
|
|
Hyperpigmented paws; PMID: 25340873 | |||||||
|
|
|
Whole organism decreased pigmentation | |||||||
|
|
|
Eye decreased pigmentation; head iridophore decreased amount; head melanocyte decreased pigmentation; melanocyte melanosome aggregated, abnormal; melanophore stripe melanosome morphology, abnormal | |||||||
|
|
|
Integument pigment granule sparse, abnormal; iridophore decreased amount; melanocyte decreased amount; trunk decreased pigmentation | |||||||
|
|
|
Diluted coat color, abnormal eye pigmentation, abnormal melanosome morphology, hypopigmentation, buff (bf) | |||||||
|
|
|
Integument melanocyte colorless; retinal pigmented epithelium melanocyte colorless | |||||||
|
|
|
Pigment cell quality, abnormal | |||||||
|
|
|
Whole organism decreased pigmentation | |||||||
|
|
|
Cell-based phenotype; increases pigmentation in human melanocytes in culture; also causes increased pigmentation in organ cultured human skin, PMID: 22951732, PMID: 24131586 | |||||||
|
|
|
Cell-based phenotype; KD blocks melanosome maturation; coordinates melanogenic gene transcription and melanosome formation via TORC1 inhibition, PMID: 21317285 | |||||||
|
|
|
PMID: 9353119, PMID: 10963668, Neural crest defects; mouse embryos deficient for both Wnt1 and Wnt3a have a marked deficiency in trunk neural crest derivatives including NC-Ms; also Wnt1 shown to regulate melanocyte development by neural crest lineage gene targeting | |||||||
|
|
|
PMID: 9353119, PMID: 22710324, PMID: 22465131, neural crest defects; mouse embryos deficient for both Wnt1 and Wnt3a have a marked deficiency in trunk neural crest derivatives including NC-Ms; also shown to promote melanogenesis | |||||||
|
|
Abnormal skin appearance, "black bumps are found on the skin of the upper surface of the paws," two independent mouse lines with similar phenotype, also cellular phenotype, PMID: 20589917, PMID: 25705850 | ||||||||
|
|
|
Dyskeratosis congenita DKCB3
(#613988) |
Reticulated skin hyperpigmentation | ||||||
|
|
|
Werner Syndrome
(#277700) |
PMID: 29146545, hypopigmentation; premature hair graying | ||||||
|
|
|
Xeroderma pigmentosum XPA
(#278700) |
Pigmented or depigmented macules and patches | ||||||
|
|
|
Xeroderma pigmentosum XPC
(#278720) |
Pigmented or depigmented macules and patches | ||||||
|
|
|
Belly spot, 14-3-3εfl/fl/14-3-3ζ−/−/Wnt1-Cre+ (conditional); conditional KO of Ywhae causes white spotting, larger spots in ko along with Ywhaz, PMID: 27001213 | |||||||
|
|
|
Belly spot; 14-3-3εfl/fl/14-3-3ζ−/−/ Wnt1-Cre+ (conditional); conditional KO of Ywhae causes white spotting, larger spots in ko along with Ywhaz, PMID: 27001213 | |||||||
|
|
|
Gray hair, melanocyte-specific KO, Yy1f/f; Tyr-Cre (conditional), visible soon after birth, loss of melanocyte development, PMID: 22570637 | |||||||
|
|
|
Skin morphology alterations; Darkened coat color, hyperkeratosis, abnormal epidermal morphology, focal areas in dermis and subcutis around hair follicles with high melanin content, Zbtb17tm1Cksn/ Zbtb17tm1Cksn; Krt14tm1(cre)Wbm/Krt14+ | |||||||
|
|
|
Hair follicle alterations; Abnormal hair shaft melanin granule morphology, clumps of pigment appear to be the remains of degenerating follicles, depilated | |||||||
|
|
Hypopigmentation, developmental loss of hair pigmentation, Zeb2fl/fl; Tyr::Cre (conditional), a.k.a. Zfhx1b; PMID: 24769727 | ||||||||
|
|
Belly spot, kumba (Ku) | zic2a = melanoblast aggregated, abnormal; melanocyte migration decreased process quality; xanthophore differentiation decreased process quality / zic2b = melanoblast aggregated, abnormal; melanocyte migration decreased process quality; xanthophore differentiation decreased process quality | |||||||
|
|
|
Mandibuloacral dysplasia with type B lipodystrophy
(#608612) |
Mottled hyperpigmentation |
Note: The previous Color Genes table (updated till 2011) is still available here.
This WEB page is maintained by Lluis Montoliu (CNB-CSIC, Madrid, Spain)